China faces significant hurdles in its ambition to become a global biotechnology leader, according to JPMorgan. The firm points to a deficit in foundational research, particularly in biological and pharmaceutical sciences, as a key area needing improvement. Additionally, geopolitical risks are identified as a factor that could impede the development of a robust innovation ecosystem within the country. AI
RANK_REASON The cluster contains an opinion piece from a financial institution about a country's industry development.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →